When will Oxford AstraZeneca COVID-19 vaccine trial in India resume? Here’s what Serum Institute says

When will Oxford AstraZeneca COVID-19 vaccine trial in India resume? Here’s what Serum Institute says

The Serum Institute of India said, “Once DCGI (Drugs Controller General of India) gives us permission to restart the trials in India, we will resume the trials.”
Check the source here –Source, Financial Express.

Leave your comment
Comment
Name
Email
Change Language